Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 111 entries
Sorted by: Best Match Show Resources per page
Balloon Devices for Atrial Fibrillation Therapy.

Arrhythmia & electrophysiology review

Metzner A, Wissner E, Lin T, Ouyang F, Kuck KH.
PMID: 26835102
Arrhythm Electrophysiol Rev. 2015 May;4(1):58-61. doi: 10.15420/aer.2015.4.1.58. Epub 2015 Apr 10.

Ablation of atrial fibrillation (AF) is an established treatment option for symptomatic patients refractory to antiarrhythmic medication. In patients with paroxysmal AF, ablation can be offered as first-line therapy when performed in an experienced centre. The accepted cornerstone for...

Cite
Metzner A, Wissner E, Lin T, et al. Balloon Devices for Atrial Fibrillation Therapy. Arrhythm Electrophysiol Rev. 2015;4(1):58-61doi: 10.15420/aer.2015.4.1.58.
Metzner, A., Wissner, E., Lin, T., Ouyang, F., & Kuck, K. H. (2015). Balloon Devices for Atrial Fibrillation Therapy. Arrhythmia & electrophysiology review, 4(1), 58-61. https://doi.org/10.15420/aer.2015.4.1.58
Metzner, Andreas, et al. "Balloon Devices for Atrial Fibrillation Therapy." Arrhythmia & electrophysiology review vol. 4,1 (2015): 58-61. doi: https://doi.org/10.15420/aer.2015.4.1.58
Metzner A, Wissner E, Lin T, Ouyang F, Kuck KH. Balloon Devices for Atrial Fibrillation Therapy. Arrhythm Electrophysiol Rev. 2015 May;4(1):58-61. doi: 10.15420/aer.2015.4.1.58. Epub 2015 Apr 10. PMID: 26835102; PMCID: PMC4711574.
Copy Download .nbib Format: NLM
Six-Year Clinical Outcomes After Catheter Ablation of Atrial Fibrillation in Patients With Impaired Left Ventricular Function.

Journal of cardiovascular electrophysiology

Rillig A, Makimoto H, Wegner J, Lin T, Heeger C, Lemes C, Fink T, Metzner A, Wissner E, Mathew S, Wohlmuth P, Kuck KH, Tilz RR, Ouyang F.
PMID: 26217925
J Cardiovasc Electrophysiol. 2015 Nov;26(11):1169-1179. doi: 10.1111/jce.12765. Epub 2015 Sep 03.

INTRODUCTION: Long-term data after pulmonary vein isolation (PVI) in patients with impaired systolic left ventricular ejection fraction (LVEF) are sparse. This study assessed the outcomes in patients with atrial fibrillation (AF) and reduced LVEF treated with PVI after a...

Cite
Rillig A, Makimoto H, Wegner J, et al. Six-Year Clinical Outcomes After Catheter Ablation of Atrial Fibrillation in Patients With Impaired Left Ventricular Function. J Cardiovasc Electrophysiol. 2015;26(11):1169-1179doi: 10.1111/jce.12765.
Rillig, A., Makimoto, H., Wegner, J., Lin, T., Heeger, C., Lemes, C., Fink, T., Metzner, A., Wissner, E., Mathew, S., Wohlmuth, P., Kuck, K. H., Tilz, R. R., & Ouyang, F. (2015). Six-Year Clinical Outcomes After Catheter Ablation of Atrial Fibrillation in Patients With Impaired Left Ventricular Function. Journal of cardiovascular electrophysiology, 26(11), 1169-1179. https://doi.org/10.1111/jce.12765
Rillig, Andreas, et al. "Six-Year Clinical Outcomes After Catheter Ablation of Atrial Fibrillation in Patients With Impaired Left Ventricular Function." Journal of cardiovascular electrophysiology vol. 26,11 (2015): 1169-1179. doi: https://doi.org/10.1111/jce.12765
Rillig A, Makimoto H, Wegner J, Lin T, Heeger C, Lemes C, Fink T, Metzner A, Wissner E, Mathew S, Wohlmuth P, Kuck KH, Tilz RR, Ouyang F. Six-Year Clinical Outcomes After Catheter Ablation of Atrial Fibrillation in Patients With Impaired Left Ventricular Function. J Cardiovasc Electrophysiol. 2015 Nov;26(11):1169-1179. doi: 10.1111/jce.12765. Epub 2015 Sep 03. PMID: 26217925.
Copy Download .nbib Format: NLM
Printing nearly-discrete magnetic patterns using chemical disorder induced ferromagnetism.

Nano letters

Bali R, Wintz S, Meutzner F, Hübner R, Boucher R, Ünal AA, Valencia S, Neudert A, Potzger K, Bauch J, Kronast F, Facsko S, Lindner J, Fassbender J.
PMID: 24377706
Nano Lett. 2014 Feb 12;14(2):435-41. doi: 10.1021/nl404521c. Epub 2014 Jan 10.

Ferromagnetism in certain alloys consisting of magnetic and nonmagnetic species can be activated by the presence of chemical disorder. This phenomenon is linked to an increase in the number of nearest-neighbor magnetic atoms and local variations in the electronic...

Cite
Bali R, Wintz S, Meutzner F, et al. Printing nearly-discrete magnetic patterns using chemical disorder induced ferromagnetism. Nano Lett. 2014;14(2):435-41doi: 10.1021/nl404521c.
Bali, R., Wintz, S., Meutzner, F., Hübner, R., Boucher, R., Ünal, A. A., Valencia, S., Neudert, A., Potzger, K., Bauch, J., Kronast, F., Facsko, S., Lindner, J., & Fassbender, J. (2014). Printing nearly-discrete magnetic patterns using chemical disorder induced ferromagnetism. Nano letters, 14(2), 435-41. https://doi.org/10.1021/nl404521c
Bali, Rantej, et al. "Printing nearly-discrete magnetic patterns using chemical disorder induced ferromagnetism." Nano letters vol. 14,2 (2014): 435-41. doi: https://doi.org/10.1021/nl404521c
Bali R, Wintz S, Meutzner F, Hübner R, Boucher R, Ünal AA, Valencia S, Neudert A, Potzger K, Bauch J, Kronast F, Facsko S, Lindner J, Fassbender J. Printing nearly-discrete magnetic patterns using chemical disorder induced ferromagnetism. Nano Lett. 2014 Feb 12;14(2):435-41. doi: 10.1021/nl404521c. Epub 2014 Jan 10. PMID: 24377706.
Copy Download .nbib Format: NLM
[Not Available].

Herzschrittmachertherapie & Elektrophysiologie

Sperzel J, Schulte B, Schwarz T, Ehrlich W, Neuzner J.
PMID: 19495633
Herzschrittmacherther Elektrophysiol. 2000 Jan;11:31-2. doi: 10.1007/BF03042517.

No abstract available.

Cite
Sperzel J, Schulte B, Schwarz T, et al. Chronische biventrikuläre Stimulation bei fortgeschrittener Herzinsuffizienz: Erfahrungen mit unterschiedlichen Elektrodensystemen. [Not Available]. Herzschrittmacherther Elektrophysiol. 2000;11:31-2doi: 10.1007/BF03042517.
Sperzel, J., Schulte, B., Schwarz, T., Ehrlich, W., & Neuzner, J. (2000). Chronische biventrikuläre Stimulation bei fortgeschrittener Herzinsuffizienz: Erfahrungen mit unterschiedlichen Elektrodensystemen. [Not Available]. Herzschrittmachertherapie & Elektrophysiologie, 1131-2. https://doi.org/10.1007/BF03042517
Sperzel, J, et al. "Chronische biventrikuläre Stimulation bei fortgeschrittener Herzinsuffizienz: Erfahrungen mit unterschiedlichen Elektrodensystemen." [Not Available]. Herzschrittmachertherapie & Elektrophysiologie vol. 11 (2000): 31-2. doi: https://doi.org/10.1007/BF03042517
Sperzel J, Schulte B, Schwarz T, Ehrlich W, Neuzner J. Chronische biventrikuläre Stimulation bei fortgeschrittener Herzinsuffizienz: Erfahrungen mit unterschiedlichen Elektrodensystemen. [Not Available]. Herzschrittmacherther Elektrophysiol. 2000 Jan;11:31-2. doi: 10.1007/BF03042517. German. PMID: 19495633.
Copy Download .nbib Format: NLM
A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Serruys PW, Ruygrok P, Neuzner J, Piek JJ, Seth A, Schofer JJ, Richardt G, Wiemer M, Carrié D, Thuesen L, Boone E, Miquel-Herbert K, Daemen J.
PMID: 19755303
EuroIntervention. 2006 Nov;2(3):286-94.

BACKGROUND: Everolimus has been successfully tested in humans using both an erodable and a durable polymer in small previous studies.METHODS: This single blind multi-centre non-inferiority randomised (3:1) controlled trial evaluated the safety and performance of the XIENCE V Everolimus...

Cite
Serruys PW, Ruygrok P, Neuzner J, et al. A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial. EuroIntervention. 2006;2(3):286-94
Serruys, P. W., Ruygrok, P., Neuzner, J., Piek, J. J., Seth, A., Schofer, J. J., Richardt, G., Wiemer, M., Carrié, D., Thuesen, L., Boone, E., Miquel-Herbert, K., & Daemen, J. (2006). A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2(3), 286-94.
Serruys, Patrick W, et al. "A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 2,3 (2006): 286-94.
Serruys PW, Ruygrok P, Neuzner J, Piek JJ, Seth A, Schofer JJ, Richardt G, Wiemer M, Carrié D, Thuesen L, Boone E, Miquel-Herbert K, Daemen J. A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial. EuroIntervention. 2006 Nov;2(3):286-94. PMID: 19755303.
Copy Download .nbib Format: NLM
Efficient teleportation between remote single-atom quantum memories.

Physical review letters

Nölleke C, Neuzner A, Reiserer A, Hahn C, Rempe G, Ritter S.
PMID: 25166964
Phys Rev Lett. 2013 Apr 05;110(14):140403. doi: 10.1103/PhysRevLett.110.140403. Epub 2013 Apr 02.

We demonstrate teleportation of quantum bits between two single atoms in distant laboratories. Using a time-resolved photonic Bell-state measurement, we achieve a teleportation fidelity of (88.0 ± 1.5)%, largely determined by our entanglement fidelity. The low photon collection efficiency...

Cite
Nölleke C, Neuzner A, Reiserer A, et al. Efficient teleportation between remote single-atom quantum memories. Phys Rev Lett. 2013;110(14):140403doi: 10.1103/PhysRevLett.110.140403.
Nölleke, C., Neuzner, A., Reiserer, A., Hahn, C., Rempe, G., & Ritter, S. (2013). Efficient teleportation between remote single-atom quantum memories. Physical review letters, 110(14), 140403. https://doi.org/10.1103/PhysRevLett.110.140403
Nölleke, Christian, et al. "Efficient teleportation between remote single-atom quantum memories." Physical review letters vol. 110,14 (2013): 140403. doi: https://doi.org/10.1103/PhysRevLett.110.140403
Nölleke C, Neuzner A, Reiserer A, Hahn C, Rempe G, Ritter S. Efficient teleportation between remote single-atom quantum memories. Phys Rev Lett. 2013 Apr 05;110(14):140403. doi: 10.1103/PhysRevLett.110.140403. Epub 2013 Apr 02. PMID: 25166964.
Copy Download .nbib Format: NLM
Congenital right lung hypoplasia associated with dextrocardia.

Journal of the Saudi Heart Association

Saeed G, Gradaus R, Neuzner J.
PMID: 25278729
J Saudi Heart Assoc. 2014 Oct;26(4):234-5. doi: 10.1016/j.jsha.2014.05.004. Epub 2014 May 22.

No abstract available.

Cite
Saeed G, Gradaus R, Neuzner J. Congenital right lung hypoplasia associated with dextrocardia. J Saudi Heart Assoc. 2014;26(4):234-5doi: 10.1016/j.jsha.2014.05.004.
Saeed, G., Gradaus, R., & Neuzner, J. (2014). Congenital right lung hypoplasia associated with dextrocardia. Journal of the Saudi Heart Association, 26(4), 234-5. https://doi.org/10.1016/j.jsha.2014.05.004
Saeed, Giovanni, et al. "Congenital right lung hypoplasia associated with dextrocardia." Journal of the Saudi Heart Association vol. 26,4 (2014): 234-5. doi: https://doi.org/10.1016/j.jsha.2014.05.004
Saeed G, Gradaus R, Neuzner J. Congenital right lung hypoplasia associated with dextrocardia. J Saudi Heart Assoc. 2014 Oct;26(4):234-5. doi: 10.1016/j.jsha.2014.05.004. Epub 2014 May 22. PMID: 25278729; PMCID: PMC4179899.
Copy Download .nbib Format: NLM
Sulfur- and Selenium-Containing Compounds Potentially Exhibiting Al Ion Conductivity.

Chemistry (Weinheim an der Bergstrasse, Germany)

Meutzner F, Zschornak M, Kabanov AA, Nestler T, Leisegang T, Blatov VA, Meyer DC.
PMID: 31012511
Chemistry. 2019 Jun 26;25(36):8623-8629. doi: 10.1002/chem.201901438. Epub 2019 May 30.

We have created a set of crystalline model structures exhibiting straight lines of Al

Cite
Meutzner F, Zschornak M, Kabanov AA, et al. Sulfur- and Selenium-Containing Compounds Potentially Exhibiting Al Ion Conductivity. Chemistry. 2019;25(36):8623-8629doi: 10.1002/chem.201901438.
Meutzner, F., Zschornak, M., Kabanov, A. A., Nestler, T., Leisegang, T., Blatov, V. A., & Meyer, D. C. (2019). Sulfur- and Selenium-Containing Compounds Potentially Exhibiting Al Ion Conductivity. Chemistry (Weinheim an der Bergstrasse, Germany), 25(36), 8623-8629. https://doi.org/10.1002/chem.201901438
Meutzner, Falk, et al. "Sulfur- and Selenium-Containing Compounds Potentially Exhibiting Al Ion Conductivity." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 25,36 (2019): 8623-8629. doi: https://doi.org/10.1002/chem.201901438
Meutzner F, Zschornak M, Kabanov AA, Nestler T, Leisegang T, Blatov VA, Meyer DC. Sulfur- and Selenium-Containing Compounds Potentially Exhibiting Al Ion Conductivity. Chemistry. 2019 Jun 26;25(36):8623-8629. doi: 10.1002/chem.201901438. Epub 2019 May 30. PMID: 31012511.
Copy Download .nbib Format: NLM
Correction to: Acute and long-term outcomes of epicardial left atrial appendage ligation with the second-generation LARIAT device: a high-volume electrophysiology center experience.

Clinical research in cardiology : official journal of the German Cardiac Society

Fink T, Schlüter M, Tilz RR, Heeger CH, Lemes C, Maurer T, Reissmann B, Rottner L, Santoro F, Mathew S, Rillig A, Ouyang F, Kuck KH, Metzner A.
PMID: 29968195
Clin Res Cardiol. 2018 Dec;107(12):1196. doi: 10.1007/s00392-018-1322-3.

Unfortunately, an error occurred in the conclusion section of this article. The corrected conclusion text is given below.

Cite
Fink T, Schlüter M, Tilz RR, et al. Correction to: Acute and long-term outcomes of epicardial left atrial appendage ligation with the second-generation LARIAT device: a high-volume electrophysiology center experience. Clin Res Cardiol. 2018;107(12):1196doi: 10.1007/s00392-018-1322-3.
Fink, T., Schlüter, M., Tilz, R. R., Heeger, C. H., Lemes, C., Maurer, T., Reissmann, B., Rottner, L., Santoro, F., Mathew, S., Rillig, A., Ouyang, F., Kuck, K. H., & Metzner, A. (2018). Correction to: Acute and long-term outcomes of epicardial left atrial appendage ligation with the second-generation LARIAT device: a high-volume electrophysiology center experience. Clinical research in cardiology : official journal of the German Cardiac Society, 107(12), 1196. https://doi.org/10.1007/s00392-018-1322-3
Fink, Thomas, et al. "Correction to: Acute and long-term outcomes of epicardial left atrial appendage ligation with the second-generation LARIAT device: a high-volume electrophysiology center experience." Clinical research in cardiology : official journal of the German Cardiac Society vol. 107,12 (2018): 1196. doi: https://doi.org/10.1007/s00392-018-1322-3
Fink T, Schlüter M, Tilz RR, Heeger CH, Lemes C, Maurer T, Reissmann B, Rottner L, Santoro F, Mathew S, Rillig A, Ouyang F, Kuck KH, Metzner A. Correction to: Acute and long-term outcomes of epicardial left atrial appendage ligation with the second-generation LARIAT device: a high-volume electrophysiology center experience. Clin Res Cardiol. 2018 Dec;107(12):1196. doi: 10.1007/s00392-018-1322-3. PMID: 29968195.
Copy Download .nbib Format: NLM
Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation-Insights from the German Ablation Registry.

Pharmacology research & perspectives

Schleberger R, Metzner A, Kuck KH, Andresen D, Willems S, Hoffmann E, Deneke T, Eckardt L, Brachmann J, Hochadel M, Senges J, Rillig A.
PMID: 34664789
Pharmacol Res Perspect. 2021 Dec;9(6):e00880. doi: 10.1002/prp2.880.

Data on the optimal treatment strategy for antiarrhythmic drug therapy (AAD) after catheter ablation for atrial fibrillation (AF) are inconsistent. The present study investigates whether postinterventional AAD leads to an improved long-term outcome. Patients from the prospective German Ablation...

Cite
Schleberger R, Metzner A, Kuck KH, et al. Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation-Insights from the German Ablation Registry. Pharmacol Res Perspect. 2021;9(6):e00880doi: 10.1002/prp2.880.
Schleberger, R., Metzner, A., Kuck, K. H., Andresen, D., Willems, S., Hoffmann, E., Deneke, T., Eckardt, L., Brachmann, J., Hochadel, M., Senges, J., & Rillig, A. (2021). Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation-Insights from the German Ablation Registry. Pharmacology research & perspectives, 9(6), e00880. https://doi.org/10.1002/prp2.880
Schleberger, Ruben, et al. "Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation-Insights from the German Ablation Registry." Pharmacology research & perspectives vol. 9,6 (2021): e00880. doi: https://doi.org/10.1002/prp2.880
Schleberger R, Metzner A, Kuck KH, Andresen D, Willems S, Hoffmann E, Deneke T, Eckardt L, Brachmann J, Hochadel M, Senges J, Rillig A. Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation-Insights from the German Ablation Registry. Pharmacol Res Perspect. 2021 Dec;9(6):e00880. doi: 10.1002/prp2.880. PMID: 34664789; PMCID: PMC8525107.
Copy Download .nbib Format: NLM
Reduction in left atrial and pulmonary vein dimensions after ablation therapy is mediated by scar.

International journal of cardiology. Heart & vasculature

Rottner L, Metzner A, Rillig A.
PMID: 35024425
Int J Cardiol Heart Vasc. 2021 Dec 31;38:100928. doi: 10.1016/j.ijcha.2021.100928. eCollection 2022 Feb.

No abstract available.

Cite
Rottner L, Metzner A, Rillig A. Reduction in left atrial and pulmonary vein dimensions after ablation therapy is mediated by scar. Int J Cardiol Heart Vasc. 2021;38:100928doi: 10.1016/j.ijcha.2021.100928.
Rottner, L., Metzner, A., & Rillig, A. (2022). Reduction in left atrial and pulmonary vein dimensions after ablation therapy is mediated by scar. International journal of cardiology. Heart & vasculature, 38100928. https://doi.org/10.1016/j.ijcha.2021.100928
Rottner, Laura, et al. "Reduction in left atrial and pulmonary vein dimensions after ablation therapy is mediated by scar." International journal of cardiology. Heart & vasculature vol. 38 (2022): 100928. doi: https://doi.org/10.1016/j.ijcha.2021.100928
Rottner L, Metzner A, Rillig A. Reduction in left atrial and pulmonary vein dimensions after ablation therapy is mediated by scar. Int J Cardiol Heart Vasc. 2021 Dec 31;38:100928. doi: 10.1016/j.ijcha.2021.100928. eCollection 2022 Feb. PMID: 35024425; PMCID: PMC8733266.
Copy Download .nbib Format: NLM
The established and the challenger: A direct comparison of current cryoballoon technologies for pulmonary vein isolation.

Journal of cardiovascular electrophysiology

Moser F, Rottner L, Moser J, Schleberger R, Lemoine M, Münkler P, Dinshaw L, Kirchhof P, Reissmann B, Ouyang F, Rillig A, Metzner A.
PMID: 34766404
J Cardiovasc Electrophysiol. 2021 Nov 11; doi: 10.1111/jce.15288. Epub 2021 Nov 11.

INTRODUCTION: Cryoballoon (CB) ablation for pulmonary vein isolation (PVI) is an effective treatment of atrial fibrillation (AF). Recently, a novel cryoablation system was introduced. The aim of the study was to compare the safety, efficacy and biophysical characteristics of...

Cite
Moser F, Rottner L, Moser J, et al. The established and the challenger: A direct comparison of current cryoballoon technologies for pulmonary vein isolation. J Cardiovasc Electrophysiol. 2021;doi: 10.1111/jce.15288.
Moser, F., Rottner, L., Moser, J., Schleberger, R., Lemoine, M., Münkler, P., Dinshaw, L., Kirchhof, P., Reissmann, B., Ouyang, F., Rillig, A., & Metzner, A. (2021). The established and the challenger: A direct comparison of current cryoballoon technologies for pulmonary vein isolation. Journal of cardiovascular electrophysiology, . https://doi.org/10.1111/jce.15288
Moser, Fabian, et al. "The established and the challenger: A direct comparison of current cryoballoon technologies for pulmonary vein isolation." Journal of cardiovascular electrophysiology vol. (2021). doi: https://doi.org/10.1111/jce.15288
Moser F, Rottner L, Moser J, Schleberger R, Lemoine M, Münkler P, Dinshaw L, Kirchhof P, Reissmann B, Ouyang F, Rillig A, Metzner A. The established and the challenger: A direct comparison of current cryoballoon technologies for pulmonary vein isolation. J Cardiovasc Electrophysiol. 2021 Nov 11; doi: 10.1111/jce.15288. Epub 2021 Nov 11. PMID: 34766404.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 111 entries